TY - CHAP
T1 - Senescence and cell cycle control
AU - Kiyokawa, Hiroaki
PY - 2006
Y1 - 2006
N2 - In response to various stresses, such as telomere shortening during continuous proliferation, oxidative stress, DNA damage and aberrant oncogene activation, normal cells undergo cellular senescence, which is a stable postmitotic state with particular morphology and metabolism. Signaling that induces senescence involves two major tumor suppressor cascades, i.e., the INK4a-Rb pathway and the ARF-p53 pathway. Diverse stimuli upregulate these interacting pathways, which orchestrate exit from the cell cycle. Recent studies have provided insights into substantial differences in senescence-inducing signals in primary cells of human and rodent origins. This review is focused on recent advances in understanding the roles of the tumor-suppressive pathways in senescence.
AB - In response to various stresses, such as telomere shortening during continuous proliferation, oxidative stress, DNA damage and aberrant oncogene activation, normal cells undergo cellular senescence, which is a stable postmitotic state with particular morphology and metabolism. Signaling that induces senescence involves two major tumor suppressor cascades, i.e., the INK4a-Rb pathway and the ARF-p53 pathway. Diverse stimuli upregulate these interacting pathways, which orchestrate exit from the cell cycle. Recent studies have provided insights into substantial differences in senescence-inducing signals in primary cells of human and rodent origins. This review is focused on recent advances in understanding the roles of the tumor-suppressive pathways in senescence.
UR - http://www.scopus.com/inward/record.url?scp=33748358764&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748358764&partnerID=8YFLogxK
U2 - 10.1007/400_001
DO - 10.1007/400_001
M3 - Chapter
C2 - 16903214
AN - SCOPUS:33748358764
SN - 3540345523
SN - 9783540345527
T3 - Results and Problems in Cell Differentiation
SP - 257
EP - 270
BT - Cell Cycle Regulation
A2 - Kaldiss, Philipp
ER -